No retraction, correction or concern found when last checked on Nov 4, 2026.
Coronavirus Nsp10, a Critical Co-factor for Activation of Multiple Replicative Enzymes
Mickaël Bouvet, Adrien Lugari, Clara C. Posthuma and 12 more
Journal of Biological Chemistry · 2014 · CC BY
Abstract
The RNA-synthesizing machinery of the severe acute respiratory syndrome Coronavirus (SARS-CoV) is composed of 16 non-structural proteins (nsp1-16) encoded by ORF1a/1b. The 148-amino acid nsp10 subunit contains two zinc fingers and is known to interact with both nsp14 and nsp16, stimulating their respective 3'-5' exoribonuclease and 2'-O-methyltransferase activities. Using alanine-scanning mutagenesis, in cellulo bioluminescence resonance energy transfer experiments, and in vitro pulldown assays, we have now identified the key residues on the nsp10 surface that interact with nsp14. The functional consequences of mutations introduced at these positions were first evaluated biochemically by monitoring nsp14 exoribonuclease activity. Disruption of the nsp10-nsp14 interaction abrogated the nsp10-driven activation of the nsp14 exoribonuclease. We further showed that the nsp10 surface interacting with nsp14 overlaps with the surface involved in the nsp10-mediated activation of nsp16 2'-O-methyltransferase activity, suggesting that nsp10 is a major regulator of SARS-CoV replicase function. In line with this notion, reverse genetics experiments supported an essential role of the nsp10 surface that interacts with nsp14 in SARS-CoV replication, as several mutations that abolished the interaction in vitro yielded a replication-negative viral phenotype. In contrast, mutants in which the nsp10-nsp16 interaction was disturbed proved to be crippled but viable. These experiments imply that the nsp10 surface that interacts with nsp14 and nsp16 and possibly other subunits of the viral replication complex may be a target for the development of antiviral compounds against pathogenic coronaviruses.
Cited by papers we hold 10
- Structure and dynamics of SARS-CoV-2 proofreading exoribonuclease ExoN · 2022No notice
- Translational shutdown and evasion of the innate immune response by SARS-CoV-2 NSP14 protein · 2021No notice
- Structural basis of ribosomal frameshifting during translation of the SARS-CoV-2 RNA genome · 2021No notice
- Structural Characterization of SARS-CoV-2: Where We Are, and Where We Need to Be · 2020No notice
- A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping · 2020No notice
- The Enzymatic Activity of the nsp14 Exoribonuclease Is Critical for Replication of MERS-CoV and SARS-CoV-2 · 2020No notice
- COVID-19: Coronavirus Vaccine Development Updates · 2020No notice
- High-resolution structures of the SARS-CoV-2 2′- O -methyltransferase reveal strategies for structure-based inhibitor design · 2020No notice
- The Curious Case of the Nidovirus Exoribonuclease: Its Role in RNA Synthesis and Replication Fidelity · 2019No notice
- Structural and molecular basis of mismatch correction and ribavirin excision from coronavirus RNA · 2017No notice
Reads
Read by people on this page
None yet.
Checked or read by AI through naulon
None yet.
A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.
Are you an author?
Is this your paper?
Claim it to add your note and be paid when agents cite it. Free.